Display options
Share it on

J Virol. 2011 Apr;85(7):3046-54. doi: 10.1128/JVI.02209-10. Epub 2011 Jan 12.

Polyomavirus middle T-antigen is a transmembrane protein that binds signaling proteins in discrete subcellular membrane sites.

Journal of virology

Alice Y Zhou, Natalia Ichaso, Adam Adamarek, Vojtech Zila, Jitka Forstova, Nicholas J Dibb, Stephen M Dilworth

Affiliations

  1. Cell Transformation Group, Section of Investigative Medicine, IRDB Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, United Kingdom.

PMID: 21228238 PMCID: PMC3067864 DOI: 10.1128/JVI.02209-10

Abstract

Murine polyomavirus middle T-antigen (MT) induces tumors by mimicking an activated growth factor receptor. An essential component of this action is a 22-amino-acid hydrophobic region close to the C terminus which locates MT to cell membranes. Here, we demonstrate that this sequence is a transmembrane domain (TMD) by showing that a hemagglutinin (HA) tag added to the MT C terminus is exposed on the outside of the cells, with the N terminus inside. To determine whether this MT TMD is inserted into the endoplasmic reticulum (ER) membrane, we added the ER retention signal KDEL to the MT C terminus (MTKDEL). This mutant protein locates only in the ER, demonstrating that MT does insert into membranes solely at this location. In addition, this ER-located MT failed to transform. Examination of the binding proteins associated with the MTKDEL protein demonstrated that it associates with PP2A and c-Src but fails to interact with ShcA, phosphatidylinositol 3-kinase (PI3K), and phospholipase C-γ1 (PLC-γ1), despite being tyrosine phosphorylated. Additional mutant and antibody studies show that MT binding to PP2A is probably required for MT to efficiently exit the ER and migrate to the plasma membrane though the TMD also plays a role in this relocation. Overall, these data, together with previous publications, illustrate that MT associates with signaling proteins at different sites in its maturation pathway. MT binds to PP2A in the cytoplasm, to c-Src at the endoplasmic reticulum, and to ShcA, PI3K, and PLC-γ1 at subsequent locations en route to the plasma membrane.

References

  1. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1059-63 - PubMed
  2. Cell. 1979 Jun;17(2):357-70 - PubMed
  3. Cell. 2008 Aug 22;134(4):634-45 - PubMed
  4. J Virol. 2005 Aug;79(15):9982-90 - PubMed
  5. EMBO J. 1995 Jul 3;14(13):3055-63 - PubMed
  6. Virology. 2009 Feb 20;384(2):304-16 - PubMed
  7. Nature. 1987 Jan 8-14;325(7000):171-3 - PubMed
  8. Cell. 1990 Jan 12;60(1):167-76 - PubMed
  9. Mol Cell Biol. 1984 Feb;4(2):282-9 - PubMed
  10. J Gen Virol. 1996 Jan;77 ( Pt 1):17-26 - PubMed
  11. Mol Cell Biol. 1982 Oct;2(10):1187-98 - PubMed
  12. J Biol Chem. 1994 Sep 30;269(39):23931-6 - PubMed
  13. Oncogene. 1999 May 20;18(20):3076-84 - PubMed
  14. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  15. Biochemistry. 1997 Jul 22;36(29):8873-82 - PubMed
  16. Nucleic Acids Res. 1981 May 11;9(9):2055-73 - PubMed
  17. J Virol. 1987 Feb;61(2):285-92 - PubMed
  18. J Virol. 1993 Apr;67(4):2235-44 - PubMed
  19. Nature. 1983 Jun 2-8;303(5916):435-9 - PubMed
  20. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2521-5 - PubMed
  21. EMBO J. 2001 Nov 15;20(22):6337-46 - PubMed
  22. Nature. 1981 Aug 13;292(5824):595-600 - PubMed
  23. Curr Opin Cell Biol. 2007 Aug;19(4):368-75 - PubMed
  24. J Virol. 1986 Aug;59(2):384-91 - PubMed
  25. Oncogene. 1998 Oct 8;17(14):1797-806 - PubMed
  26. Cell. 1982 Aug;30(1):123-30 - PubMed
  27. Nature. 1994 Feb 17;367(6464):654-7 - PubMed
  28. J Virol. 1997 Jul;71(7):5512-20 - PubMed
  29. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6344-8 - PubMed
  30. J Virol. 1986 Jul;59(1):82-9 - PubMed
  31. J Biol Chem. 1995 May 26;270(21):12331-4 - PubMed
  32. Nat Rev Cancer. 2002 Dec;2(12):951-6 - PubMed
  33. Mol Cell Biol. 1992 Nov;12(11):5050-8 - PubMed
  34. EMBO J. 1986 Feb;5(2):325-34 - PubMed
  35. Nature. 1993 May 6;363(6424):83-5 - PubMed
  36. Semin Cancer Biol. 2009 Aug;19(4):211-7 - PubMed
  37. Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents - PubMed
  38. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4666-70 - PubMed
  39. Cell. 2007 Mar 23;128(6):1147-59 - PubMed
  40. Cell. 1979 Dec;18(4):925-33 - PubMed
  41. J Virol. 1987 Feb;61(2):405-10 - PubMed
  42. EMBO J. 1986 Mar;5(3):491-9 - PubMed
  43. Nature. 1988 Apr 14;332(6165):644-6 - PubMed
  44. Nature. 1994 Jan 6;367(6458):87-90 - PubMed
  45. Nature. 1993 May 6;363(6424):85-8 - PubMed
  46. Cell. 1989 Oct 6;59(1):55-65 - PubMed
  47. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3579-83 - PubMed
  48. Oncogene. 1998 Aug 6;17(5):565-76 - PubMed

Substances

MeSH terms

Publication Types

Grant support